Approval · Notice of Compliance 29940 · 2023
APO-MYCOPHENOLATE: Notice of Compliance 29940
Issued January 19, 2023
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 29940
- Date
- January 19, 2023
- Company
- Apotex Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Other
- Reason
- Update to The Product Monograph. Administrative: Labelling Update (to Match Licensor)
- Canadian reference product
- CELLCEPT (Hoffmann-La Roche Limited)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| APO-MYCOPHENOLATE | Not yet assigned | — |
Medicinal ingredients
- MYCOPHENOLATE MOFETIL 500 MG per TAB